Rb and p16 expression in non-small cell lung cancer (NSCLC).

被引：0
|
作者：
Flieder, DB
Brambilla, E
Rush, W
Przygodzki, R
Fleming, M
Freedman, A
Travis, W
Caporaso, N
Guinee, D
Bennett, W
Jones, R
Trastek, V
Pairolero, P
Tazelaar, H
Jett, J
Midthun, D
Liotta, L
Harris, CC
机构：
[1] NCI, Human Carcinogenesis Lab, Bethesda, MD 20892 USA
[2] NCI, Genet Epidemiol Branch, Bethesda, MD 20892 USA
[3] CHRU, Pathol Cellulaire Lab, Grenoble, France
[4] AFIP, Washington, DC USA
[5] Univ Utah, Dept Pathol, Salt Lake City, UT 84112 USA
[6] Mayo Clin, Rochester, MN USA
来源：
MODERN PATHOLOGY | 1998年 / 11卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
引用
收藏
页码：173A / 173A
页数：1
相关论文
共 50 条
  • [21] Expression of p16INK4a/p16α and p19ARF/p16β is frequently altered in non-small cell lung cancer and correlates with p53 overexpression
    Silvia Vonlanthen
    Jim Heighway
    Mario P Tschan
    Markus M Borner
    Hans J Altermatt
    Andreas Kappeler
    Andreas Tobler
    Martin F Fey
    Nick Thatcher
    Wendell G Yarbrough
    Daniel C Betticher
    Oncogene, 1998, 17 : 2779 - 2785
  • [22] Expression of p16 and lack of pRB in primary small cell lung cancer
    Yuan, JP
    Knorr, J
    Altmannsberger, M
    Goeckenjan, G
    Ahr, A
    Scharl, A
    Strebhardt, K
    JOURNAL OF PATHOLOGY, 1999, 189 (03): : 358 - 362
  • [23] β-catenin in non-small cell lung cancer (NSCLC)
    Swinson, DEB
    Lolljee, J
    Edwards, JG
    Jones, JL
    Cox, G
    Richardson, D
    O'Byrne, KJ
    BRITISH JOURNAL OF CANCER, 2002, 86 : S59 - S60
  • [24] Micrometastases in non-small cell lung cancer (NSCLC)
    Passlick, B
    LUNG CANCER, 2001, 34 : S25 - S29
  • [25] Immunotherapy for non-small cell lung cancer (NSCLC)
    Frost, Nikolaj
    Reck, Martin
    INNERE MEDIZIN, 2022, 63 (07): : 709 - 716
  • [26] Genotyping Non-Small Cell Lung Cancer (NSCLC)
    Delia Campos-Parra, Alma
    Cruz-Rico, Graciela
    Arrieta, Oscar
    GACETA MEXICANA DE ONCOLOGIA, 2012, 11 (01): : 35 - 44
  • [27] Treatment of non-small cell lung cancer (NSCLC)
    Zarogoulidis, Konstantinos
    Zarogoulidis, Paul
    Darwiche, Kaid
    Boutsikou, Efimia
    Machairiotis, Nikolaos
    Tsakiridis, Kosmas
    Katsikogiannis, Nikolaos
    Kougioumtzi, Ioanna
    Karapantzos, Ilias
    Huang, Haidong
    Spyratos, Dionysios
    JOURNAL OF THORACIC DISEASE, 2013, 5 : S389 - S396
  • [28] Eicosanoids in non-small cell lung cancer (NSCLC)
    Johnson, D. H.
    Horn, L.
    Zhao, Z.
    Milne, G.
    Morrow, J.
    Sandler, A.
    Shyr, Y.
    Carbone, D. P.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [29] Gemcitabine in Non-Small Cell Lung Cancer (NSCLC)
    Christian Manegold
    Petr Zatloukal
    Kurt Krejcy
    Johannes Blatter
    Investigational New Drugs, 2000, 18 : 29 - 42
  • [30] BRCAness in non-small cell lung cancer (NSCLC).
    Waqar, Saiama Naheed
    Devarakonda, Siddhartha H. K.
    Michel, Loren S.
    Maggi, Leonard B.
    Watson, Mark
    Guebert, Kalin
    Carpenter, Danielle
    Sleckman, Barry P.
    Govindan, Ramaswamy
    Morgensztern, Daniel
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
12345